Identifying and targeting the players in this metabolic adaptation that repress the adiponectin ligand or its receptor expression could be key to addressing obesity and obesity-driven pancreatic cancer. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.